Walleye Capital’s Acadia Healthcare ACHC Stock Holding History

Walleye Capital’s Portfolio ACHC Stock Details ACHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$121K	Sell	4,100 -10,000	-71%	-$257K	﹤0.01%	3781
2026 Q1	$330K	Sell	14,100 -32,000	-69%	-$579K	﹤0.01%	2995
2025 Q4	$654K	Buy	46,100 +29,400	+176%	+$556K	﹤0.01%	2767
2025 Q3	$413K	Buy	16,700 +13,000	+351%	+$290K	﹤0.01%	2774
2025 Q2	$84K	Buy	+3,700	New	+$87.7K	﹤0.01%	3849
2025 Q1	–	Sell	-300	Closed	-$11.9K	–	4161
2024 Q4	$11.9K	Sell	300 -14,600	-98%	-$659K	﹤0.01%	4565
2024 Q3	$945K	Buy	14,900 +9,600	+181%	+$693K	﹤0.01%	2708
2024 Q2	$358K	Buy	+5,300	New	+$370K	﹤0.01%	3818

Other funds holding ACHC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

CCM

Carronade Capital Management Darien, Connecticut $5.77B AUM 89.67% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

DCM

DME Capital Management New York $3.91B AUM 36.1% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

ABI

Abrams Bison Investments Bethesda, Maryland $2.05B AUM 71.03% 1-Year Est. Return

Walleye Capital's ACHC Position: Q2 2026 in Review

Walleye Capital reduced its Acadia Healthcare (ACHC) stake by 98% in Q2 2026, selling an estimated $2.76M and leaving 1,990 shares worth $58.8K. The position accounts for ﹤0.01% of the portfolio, ranked #4125.

Walleye Capital first reported a position in ACHC in Q3 2019 and has held it in 13 quarters since. The position peaked at $26.7M in Q1 2025. 314 funds tracked by Wall St. Rank hold ACHC as of Q2 2026.

Walleye Capital held 1,990 shares of Acadia Healthcare worth $58.8K as of Q2 2026.
Walleye Capital sold 107,674 Acadia Healthcare shares in Q2 2026, an estimated $2.76M.
Acadia Healthcare made up ﹤0.01% of Walleye Capital's portfolio in Q2 2026, its #4125 holding.
Walleye Capital first reported a position in Acadia Healthcare in Q3 2019 and has held it in 13 quarters since.
Walleye Capital's Acadia Healthcare position peaked at $26.7M in Q1 2025.
314 funds tracked by Wall St. Rank held Acadia Healthcare as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.